Blog

APCaRI investigator awarded 2018 Alumni Honour

Congratulations to top alumni honour awardee Dr. Ron Moore

Congratulations to Dr. Ron Moore, ’80 BSc, ’86 MD, ’91 PhD, who will receive an Alumni Honour Award from University of Alberta President David H. Turpin during the Alumni Awards Ceremony on Monday, Sept. 24, 2018, at the Northern Alberta Jubilee Auditorium in Edmonton.
The Alumni Honour Award recognizes the significant achievements and contributions by University of Alberta alumni to their profession and their community. Dr. Moore has made significant contributions to advancing our knowledge and treatment of bladder, kidney and prostate cancer. He has studied and developed laser treatment as therapy for prostate and bladder cancer, and developed new drugs to improve prostate cancer radiotherapy outcomes. Dr. Ron Moore has also actively mentored and trained hundreds of students throughout his career as well as serving on the APCaRI leadership committee.

The community is invited to celebrate as Dr. Ron Moore receives this top alumni award!
Date: Monday, Sept. 24, 2018
Location: Northern Alberta Jubilee Auditorium (11455 87 Ave), Edmonton, Alberta
Time: 7 p.m. ceremony with dessert reception to follow
Cost: Free, register for tickets
Dress: Business attire

For more information, please contact the Office of Alumni Relations at 780-492-3224, toll free 1-800-661-2593 or alumni@ualberta.ca
Featured at @UAlbertaAlumni and in the New Trail magazine.

Stay Informed

To stay up to date on all the latest news and publications, subscribe to our newsletter!

Recent Posts

15th Annual Personalized Medicine Conference Posted on Nov 9 19 at 5:14pm
Evaluating the measurement properties of EPIC-26 Posted on Nov 6 19 at 12:19pm
APCaRI 2019 Fall Symposium Posted on Oct 22 19 at 12:28pm

New platform for prostate cancer diagnosis to be presented at ISEV 2017

The Lewis Research Group will present exciting results about new blood tests for prostate cancer during 3 talks at the upcoming 2017 International Society of Extracellular Vesicles (ISEV) annual meeting in Toronto (May 18-21). ISEV is a global society of researchers studying exosomes and microvesicles, which are the exciting new focus of cancer therapy and diagnosis.

Dr. Desmond Pink will speak about “Microflow cytometry: The Apogee A50 is a sensitive standard tool for extracellular vesicle analyses in liquid biopsies”, Robert Paproski’s presentation is entitled “Using machine learning of extracellular vesicle flow cytometry to build predictive fingerprints for prostate cancer diagnosis”, and Dr. John Lewis will speak about “An extracellular vesicle blood fingerprint distinguishes between patients with indolent and aggressive prostate cancer at diagnosis”.

The team is looking forward to sharing these key advances that were made possible through the APCaRI prospective cohort.

- John Lewis